| Literature DB >> 30095058 |
A Beaumont1, A Campbell1, F Grace2, N Sculthorpe1.
Abstract
BACKGROUND: Ageing is associated with an inexorable decline in cardiac and vascular function, resulting in an increased risk of Cardiovascular Disease (CVD). Lifestyle factors such as exercise have emerged as a primary therapeutic target in the prevention of CVD, yet older individuals are frequently reported as being the least active, with few meeting the recommended physical activity guidelines. In contrast, well trained older individuals (Masters athletes) have superior functional capacity than their sedentary peers and are often comparable with young non-athletes. Therefore, the 'masters' athlete may be viewed as a unique non-pharmacological model which may allow researchers to disentangle the inexorable from the preventable and the magnitude of the unavoidable 'true' reduction in cardiac function due to ageing.Entities:
Keywords: Systolic function; athletes; cardiac remodelling; cardiac response; diastolic function; healthy ageing.
Mesh:
Year: 2018 PMID: 30095058 PMCID: PMC6300801 DOI: 10.2174/1573403X14666180810155513
Source DB: PubMed Journal: Curr Cardiol Rev ISSN: 1573-403X
Summary of studies including echocardiographic derived left ventricular structure, systolic and diastolic function in athletes and controls.
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
|
|
|
| |||||||
| Baldi | Controls (M) | 65.7 ± 3.7 | ↔ | ↔ | ↑ | ↑ | ↔ | ||
| Bhella | Controls (M+F) | 68.8 ± 5.1 | ↔ | ||||||
| Bohm | Controls (M) | 46.0 ± 9.0 | ↑ | ↑ | ↑ | ||||
| Bouvier | Controls (-) | 74.9 ± 2.4 | ↔ | ↑ | ↔ | ↔ * | ↑ | ||
| Carrick-Ranson | Controls | 66.0 ± 5.0 | ↔ | ↑ | ↑ | ||||
| Child | Controls (M) | 56.3 ± 7.8 | ↑ * | ↑ * | ↑ * | ↑ * | |||
| Cottini | Controls (-) | 61.0 ± 7.0 | ↔ | ↔ | ↔ | ↑ | ↑ | ||
| D’Andrea | Controls (M) | 47.4 ± 2.2 | ↔ | ↔ | ↑ | ↑ * | ↑ | ||
| Di Bello | Controls (M) | 69.7 ± 8.4 | ↑ | ↑ | ↔ | ↑ | ↑ | ↔ | |
| Donal | Controls (M) | 58.9 ± 8.6 | ↑ | ↑ | ↔ | ↑ * | ↔ | ↔ | |
| Douglas and O’Toole. [ | Controls (M+F) | 65.0 ± 6.0 | ↔ | ↑ | ↔ | ↑ | |||
| Fleg | Controls (M) | 63.0 ± 6.0 | ↔ * | ↔ * | ↔ * | ↔ * | ↔ | ||
| Galetta | Controls (M) | 66.9 ± 4.6 | ↑ | ↑ | ↑ | ↑ | ↔ | ↔ | |
| Galetta | Controls (M) | 68.3 ± 3.2 | ↑ | ↑ | ↑ | ↑ | ↑ | ↔ | |
| Gates | Controls (M) | 65.0 ± 6.6 | ↑ * | ↑ * | ↑ * | ↑ | |||
| Giada | Controls (M) | 58.0 ± 6.0 | ↑ * | ↑ * | ↑ * | ↑ * | ↔ | ↔ | |
| Grace | Controls (M) | 62.7 ± 5.2 | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | |
| Jungblut | Controls (M) | 69.0 ± 3.0 | ↔ | ↔ | ↑ | ↑ * | ↔ | ||
| Kozakova | Controls (M) | 46.5 ± 16.0 | ↑ | ↑ | ↔ | ↑ | |||
| Lee | Controls (M) | 54.8 ± 4.3 | ↔ | ↔ | ↔ | ↑ * | ↔ | ↔ | |
| Lindsey and Dunn [ | Controls (M) | 52.0 ± - | ↑ | ↑ | ↑ | ↑ * | ↔ | ||
| Maessen | Controls (M) | 58.0 ± 7.0 | ↔ | ||||||
| Matelot | Controls (M) | 59.0 ± 3.0 | ↔ | ↑ | ↔ | ↔ | ↔ | ||
| Maufrais | Controls (-) | 56.0 ± 6.0 | ↑ | ↑ | ↑ * | ↑ | |||
| Maufrais | Controls (M) | 55.0 ± 8.0 | ↑ | ↑ * | |||||
| Miki | Controls (-) | 49.0 ± 7.6 | ↑ * | ↑ * | ↑ * | ||||
| Molmen | Controls (M) | 71.7 ± 1.3 | ↔ | ↔ | |||||
| Nishimura | Controls (M) | 46.9 ± 3.3 | ↑ | ↑ | ↑ | ↑ | ↓ | ||
| Northcote | Controls (M) | 56.0 ± 7.0 | ↔ | ↑ | ↔ | ↑ | |||
| Nottin | Controls (M) | 55.9 ± 4.1 | ↔ * | ↔ * | ↑ * | ↔ * | ↑ | ↔ | |
| Olsen | Controls (M) | 66.3 ± 3.8 | ↑ | ↑ | ↑ | ↑ | ↔ | ||
| Prasad | Controls (M+F) | 69.8 ± 3.0 | ↔ | ↑ * | ↑ | ↔ | |||
| Seals | Controls (M) | 63.0 ± 3.0 | ↑ * | ↑ * | |||||
| Schmidt | Controls (M) | 68.2 ± 3.2 | ↔ | ↔ | ↔ | ↔ | ↔ | ↑ | |
| Takemoto | Controls (M+F) | 60.0 ± 5.0 | ↑ | ||||||
| Vianello | Controls (M+F) | 57.0 ± 10.0 | ↑ | ↑ | ↑ | ↑ * | ↑ | ↓ | |
M, male; F, female; IVS, interventricular septal thickness; PWT, posterior wall thickness; MWT, mean wall thickness; LVEDD, left ventricular end-diastolic diameter, LVM, left ventricular mass; E/A, early-to-late mitral inflow velocity; EF, ejection fraction. *, indicates allometrically scaled indices; ↑, significantly greater in athletes as reported by study; ↓, significantly lower in athletes as reported by study; ↔, no significant difference between athletes and controls as reported by study. Data presented as means ± standard deviation.